Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Vinciane Saint-Criq

Newcastle AuthorsTitleYearFull text
Dr Iram Haq
Dr Mike Althaus
Dr Vinciane Saint-Criq
Dr Bernard Verdon
Dr Jen Townshend
et al.
Clinical and molecular characterisation of the R751L-CFTR mutation2021
Dr Vinciane Saint-Criq
Livia Delpiano
JinHeng Lin
Dr Michael Gray
Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors2021
Dr Vinciane Saint-Criq
Livia Delpiano
John Casement
Jennifer Chika Onuora
Jia-Yu Lin
et al.
Choice of Differentiation Media Significantly Impacts Cell Lineage and Response to CFTR Modulators in Fully Differentiated Primary Cultures of Cystic Fibrosis Human Airway Epithelial Cells2020
Dr Emily Mavin
Dr Bernard Verdon
Sean Carrie
Dr Vinciane Saint-Criq
Jason Powell
et al.
Real-time measurement of cellular bioenergetics in fully differentiated human nasal epithelial 2 cells grown at air-liquid-interface2020
Dr Aaron Ions Gardner
Dr Iram Haq
Professor John Simpson
Dr Vinciane Saint-Criq
Dr Bernard Verdon
et al.
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis2020
Dr Vinciane Saint-Criq
Dr Iram Haq
Dr Aaron Ions Gardner
Professor Christopher Ward
Dr Malcolm Brodlie
et al.
Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells2019
Dr Vinciane Saint-Criq
Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway2018
Dr Vinciane Saint-Criq
Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation2018
Livia Delpiano
Dr Sarah Rice
Dr Michael Gray
Dr Vinciane Saint-Criq
Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells2018
Dr Vinciane Saint-Criq
Ion channels as targets to treat cystic fibrosis lung disease2018
12